Effects of glucagon on plasma amino acids.
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The effects of glucagon deficiency and excess on plasma concentrations of 21 amino acids were studied in six normal human subjects for 8 h. During glucagon deficiency, produced by intravenous infusion of somatostatin (0.5 mg/h) and insulin (5 mU/kg per h), amino acid concentration (sum of 21 amino acids) rose from 2,607 +/- 76 to 2,922 +/- 133 microM after 4 h (P less than 0.025). The largest increases occurred in lysine (+26%), glycine (+24%), alanine (+23%), and arginine (+23%) concentrations. During glucagon excess produced by intravenous infusion of somatostatin (0.5 mg/h), insulin (5 mU/kg per h), and glucagon (60 ng/kg per h), amino acid concentration decreased from 2,774 +/- 166 to 2,388 +/- 102 microM at 8 h (P less than 0.01). The largest decreases occurred in citrulline (-37%), proline (-32%), ornithine (-30%), tyrosine (-23%), glycine (-20%), threonine (-21%), and alanine (18%) concentrations. Urinary urea nitrogen and total nitrogen excretions were lower during glucagon deficiency than during glucagon excess (3.1 +/- 0.2 vs. 6.3 +/- 2.3 g/8 h, P less than 0.05 and 4.8 +/- 1.0 vs 7.0 +/- 2.6 g/8 h, respectively, P less than 0.05). Biostator-controlled euglycemic glucagon deficiency was produced in four normal subjects for 4 h to eliminate possible effects of changes in glucose concentration on amino acids. Amino acid concentration (sum of 18 amino acids) increases occurred in arginine (+42%), alanine (+28%), glutamine (+25%), and glycine (+16%) concentrations. The data show that small changes (-66 pg/ml and +50 pg/ml) in basal glucagon concentrations cause plasma amino acid concentrations to change in opposite directions. The finding that urinary excretion of nitrogen and urea nitrogen was greater during glucagon excess than during glucagon deficiency suggested alterations in the rate of gluconeogenesis from amino acids as one mechanism by which glucagon controls blood amino acid levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hormone-fuel interrelationships during fasting.
Cahill, G. F., Herrera, M. G., Morgan, A. P., Soeldner, J. S., Steinke, J., Levy, P. L., Reichard, G. A., & Kipnis, D. M. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105481 · Cited by 1,036 · cited 1×
“Glycerol (17, 18), lactate, acetoacetate, beta hydroxybutyrate (19, 20), glutamine (21), and glutamate (22) were measured enzymatically.”
MethodFelig, P. (1975) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.44.070175.004441 · Cited by 789 · cited 2×
“Previous studies have shown that portal hypoinsulinemia causes an increase in the splanchnic uptake of gluconeogenic amino acids, resulting in a decrease in their peripheral concentrations without affecting the levels of branched chain amino acids (6, 29, 30).”
BackgroundAmino acid metabolism in exercising man
Felig, P., & Wahren, J. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106771 · Cited by 431
Gerich, J. E., Lorenzi, M., Bier, D. M., Tsalikian, E., Schneider, V, Karam, J. H., & Forsham, P. H. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108364 · Cited by 198
Valverde, I., Dobbs, R., & Unger, R. H. (1975) · Metabolism · doi:10.1016/0026-0495(75)90095-5 · Cited by 92 · cited 1×
“However, changes of IRG in response to stimulation or suppression has been shown to be due exclusively to changes in the IRG3500 fraction (26, 27).”
Background
Cited by
Amino acid homeostasis and signalling in mammalian cells and organisms
Bröer, S., & Bröer, A. (2017) · Biochemical Journal · doi:10.1042/bcj20160822 · Cited by 502
Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases
Alves, A., Bassot, A., Bulteau, A.-L., Pirola, L., & Morio, B. (2019) · Nutrients · doi:10.3390/nu11061356 · Cited by 365
Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice
Lee, Y., Wang, M.-Y., Du, X. Q., Charron, M. J., & Unger, R. H. (2011) · Diabetes · doi:10.2337/db10-0426 · Cited by 327
“(31) in humans in whom glucagon was suppressed by somatostatin.”
BackgroundCynober, L. A. (2002) · Nutrition · doi:10.1016/s0899-9007(02)00780-3 · Cited by 303
The glucagonoma syndrome and necrolytic migratory erythema: a clinical review
van Beek, A., de Haas, E., van Vloten, W., Lips, C., Roijers, J., & Canninga-van Dijk, M. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510531 · Cited by 202
Action and therapeutic potential of oxyntomodulin
Pocai, A. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.12.001 · Cited by 191
Bossart, M., Wagner, M., Elvert, R., Evers, A., Hübschle, T., Kloeckener, T., Lorenz, K., Moessinger, C., Eriksson, O., Velikyan, I., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.005 · Cited by 179
Winther-Sørensen, M., Galsgaard, K. D., Santos, A., Trammell, S. A. J., Sulek, K., Kuhre, R. E., Pedersen, J., Andersen, D. B., Hassing, A. S., Dall, M., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101080 · Cited by 135
“Glucagon also regulates amino acid metabolism in the liver via ureagenesis [2,3].”
BackgroundWewer Albrechtsen, N. J., Færch, K., Jensen, T. M., Witte, D. R., Pedersen, J., Mahendran, Y., Jonsson, A. E., Galsgaard, K. D., Winther-Sørensen, M., Torekov, S. S., et al. (2018) · Diabetologia · doi:10.1007/s00125-017-4535-5 · Cited by 119
“However, in addition to its glucose-regulatory effects, glucagon also regulates amino acid metabolism (ureagenesis) in the liver [5] and, conversely, amino acids stimulate the secretion of glucagon [6], forming a feedback loop between the liver and the pancreatic alpha cells [7, 8]—a liver–alpha cell axis.”
Metabolic effects of glucagon in humans
Adeva-Andany, M. M., Funcasta-Calderón, R., Fernández-Fernández, C., Castro-Quintela, E., & Carneiro-Freire, N. (2019) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.12.005 · Cited by 94
The incretin/glucagon system as a target for pharmacotherapy of obesity
Del Prato, S., Gallwitz, B., Holst, J. J., & Meier, J. J. (2022) · Obesity Reviews · doi:10.1111/obr.13372 · Cited by 77
Role of Glucagon in Catabolism and Muscle Wasting of Critical Illness and Modulation by Nutrition
Thiessen, S. E., Derde, S., Derese, I., Dufour, T., Vega, C. A., Langouche, L., Goossens, C., Peersman, N., Vermeersch, P., Vander Perre, S., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201702-0354oc · Cited by 75
Increased amino acid clearance and urea synthesis in a patient with glucagonoma.
Almdal, T. P., Heindorff, H., Bardram, L., & Vilstrup, H. (1990) · Gut · doi:10.1136/gut.31.8.946 · Cited by 49
Kazierad, D. J., Bergman, A., Tan, B., Erion, D. M., Somayaji, V., Lee, D. S., & Rolph, T. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12672 · Cited by 44
A Metabolomic Signature of Glucagon Action in Healthy Individuals With Overweight/Obesity
Vega, R. B., Whytock, K. L., Gassenhuber, J., Goebel, B., Tillner, J., Agueusop, I., Truax, A. D., Yu, G., Carnero, E., Kapoor, N., et al. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab118 · Cited by 24
Triple Agonism Based Therapies for Obesity
Goldney, J., Hamza, M., Surti, F., Davies, M. J., & Papamargaritis, D. (2025) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-025-00770-z · Cited by 22
Li, W., Kirchner, T., Ho, G., Bonilla, F., D'Aquino, K., Littrell, J., Zhang, R., Jian, W., Qiu, X., Zheng, S., et al. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14173 · Cited by 20
Trinh, B., Peletier, M., Simonsen, C., Plomgaard, P., Karstoft, K., Pedersen, B. K., van Hall, G., & Ellingsgaard, H. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac239 · Cited by 7
Metadata
- Authors
- Boden, G., Rezvani, I., & Owen, O. E.
- Venue
- Journal of Clinical Investigation
- Published
- 1984-03-01
- Volume
- 73
- Issue
- 3
- Pages
- 785-793
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2031689292
- Cited by
- 120
- References
- 5
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.